688670.SH
金迪克
SSE · Healthcare · Biotechnology · CN
CNY 15.01
−5.89%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -29.2%
- EBITDA
- -98.0%
- EBIT
- -72.6%
- Net income
- -90.7%
- EPS
- -90.8%
- Free cash flow
- -18.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026